Among the enzymes implicated in gene regulation via epigenetic mechanisms, the enhancer of zeste homolog 2 (EZH2) is an important histone methyltransferase that methylates H3K27 leading to the transcriptional silencing of the target genes in breast cancer. The gene discussed is PRDM9; the disease is breast carcinoma.